Clinical trial
IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who…
NCT00041223 · Royal Marsden NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00041223 |
|---|---|
| Title | IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer |
| Official title | Double-Blind, Placebo-Controlled, Randomized Phase II Trial of IH636 Grape Seed Proanthocyanidin Extract (GSPE) in Patients With Adverse Effects of High Dose Breast Radiotherapy |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Radiation Fibrosis |
| Intervention type | Dietary Supplement |
| Interventions | IH636 grape seed proanthocyanidin extract |
| Start date | Sep 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: